These results imply that targeting FLG2 could be instrumental in forestalling the initiation and progression of a multitude of skin disorders, including atopic dermatitis and intrinsic skin aging, by restoring the compromised barrier function of the skin. Here, FLG2 is linked to atopic eczema.